The Relation Between VIIIR:AG and VIII:C Studied with Two Antisera

1979 ◽  
Author(s):  
H. P. Muller ◽  
N. H. van Tilburg ◽  
R. M. Bertina ◽  
J. J. Veltkamp
Keyword(s):  
Molecular Weight ◽  
High Salt ◽  
Low Molecular Weight ◽  
Gel Chromatography ◽  
Specific Antibodies ◽  
Specific Effects ◽  
Normal Plasma ◽  
Coagulant Activity ◽  
Sterical Hindrance ◽  
Inhibitory Antibodies

FVIII was separated into low molecular weight FVIII (LMW FVIII) and high molecular weight FVIII (HMW FVIII) by gel chromatography in the presence of high salt concentration or by high salt elution of LMW FVIII from FVIII bound to anti HMW FVII-Sepharose. Specific antibodies were raised in rabbits against HMW FVIII and LMW FVIII. After removal of the contaminating anti HMW activities the rabbit anti LMW FVIII was still able to neutralize the FVIII coagulant activity of normal plasma and of IMW FVIII with canparable efficiency and it had no effect on the VIIIR:WF of FVIII in normal plasma or in HMW FVIII. Anti LMW FVIII does not bind to HMW FVIII and does not precipitate FVIII as tested by counter immunoelectrophoresis. Rabbit anti HMW FVIII precipitates FVIII in normal plasma, inhibits VIIIR:WF activity, while it has no effect on the FVIII coagulant activity of LMW FVIII. The coagulant activity of FVIII in normal plasma is slightly inhibited by anti HMW FVIII presumably by non-specific effects (sterical hindrance). It is concluded that inhibitory antibodies against VIII:C raised in rabbits recognize antigenic structures only present on LMW FVIII. Antibodies against HMW FVIII raised in rabbits appears to recognize structures only present on HMW FVIII.

The Relation Between VIIIR:AG and VIII:C Studied with two Antisera

1979 ◽  
Author(s):  
H. P. Muller ◽  
N.H. van Tilburg ◽  
R.M. Bertina ◽  
J. J. Voltkamp
Keyword(s):  
Molecular Weight ◽  
High Salt ◽  
Low Molecular Weight ◽  
Gel Chromatography ◽  
Specific Antibodies ◽  
Specific Effects ◽  
Normal Plasma ◽  
Coagulant Activity ◽  
Sterical Hindrance ◽  
Inhibitory Antibodies

FVIII was separated into low molecular weight FVIII (LMW FVIII) and high molecular weight FVIII (HMW FVIII) by gel chromatography in the presence of high salt concentration or by high salt elution of LMW FVIII from FVIII bound to anti HMW FVII-Sepharose. Specific antibodies were raised in rabbits against HMW FVIII and LMW FVIII. Mter rsroval of the contaminating anti HMW activities the rabbit anti LMW FVIII was still able to neutralize the FVIII coagulant activity of normal plaana and of LMW FVIII with comparable efficiency and it had no effect on the VIIIR:WF of FVIII in normal plasma or in HMW FVIII. Anti LMW FVIII does not bind to HMW FVIII and does not precipitate FVIII as tested by counter Immunoelectrophoresis. Rabbit anti HMW FVIII precipitates FVIII in normal plasma, inhibits VIIIR:WF activity, while it has no effect on the FVIII coagulant activity of LMW FVIII. The coagulant activity of FVIII in normal plasma is slightly inhibited by anti HMW FVIII presumably by non-specific effects (sterical hindrance). It is concluded that inhibitory antibodies against VIII:C raised in rabbits recognize antigenic structures only present on LMW FVIII. Antibodies against HMW FVIII raised in rabbits appears to recognize structures only present on HMW FVIII.

Hepatic Metallothionein in Rainbow Trout (Salmo gairdneri) as an Indicator of Metal Pollution in the Campbell River System

1982 ◽  
Vol 39 (12) ◽  
pp. 1596-1601 ◽  
Author(s):  
M. Roch ◽  
J. A. McCarter ◽  
A. T. Matheson ◽  
M. J. R. Clark ◽  
R. W. Olafson
Keyword(s):  
Molecular Weight ◽  
Rainbow Trout ◽  
Metal Pollution ◽  
Quantitative Measure ◽  
Salmo Gairdneri ◽  
Differential Pulse Polarography ◽  
Low Molecular Weight ◽  
Gel Chromatography ◽  
Hepatic Metallothionein ◽  
Molecular Weight Fractions

Hepatic metallothionein was measured in livers of freshly killed rainbow trout (Salmo gairdneri) using differential pulse polarography. The fish were caught in metal-contaminated lakes of the Campbell River watershed and in a nearby control lake. The livers were analyzed for zinc, copper, and cadmium using atomic absorption spectrophotometry. High and low molecular weight protein fractions were separated by gel chromatography from liver cytosols and analyzed for metals. A downward trend from the most contaminated lake to the least was found in levels of zinc in the water, of cadmium and copper in high molecular weight fractions, and of copper in low molecular weight fractions and metallothionein. The concentration of metallothionein is a useful quantitative measure of the degree of exposure of fish to heavy metals.Key words: metallothionein, rainbow trout, Salmo gairdneri; heavy metal pollution, sublethal exposures, mine wastes

scholarly journals Detection, purification and characterization of a human cancer-associated galactosyltransferase acceptor

1979 ◽  
Vol 178 (2) ◽  
pp. 279-287 ◽  
Author(s):  
D K Podolsky ◽  
M M Weiser
Keyword(s):  
Molecular Weight ◽  
Human Cancer ◽  
Deae Cellulose ◽  
Structural Data ◽  
Low Molecular Weight ◽  
Gel Chromatography ◽  
Purification And Characterization ◽  
Peptide Moiety ◽  
Cellulose Column

A low-molecular-weight acceptor of galactosyltransferase activity was detected in sera and effusions of patients with extensive maligant disease. This substance was purified to homogeneity from both human serum and effusion by using sequential charcoal/Celite and DEAE-cellulose column chromatography. The purified acceptor was shown to act as substrate for both purified normal and cancer-associated human galactosyltransferase (EC 2.4.1.22) isoenzymes, but had a higher affinity for the cancer-associated isoenzyme (Km = 20 microM) than for the normal isoenzyme (Km = 500 microM). The substrate was found to be a glycopeptide with mol.wt. approx. 3600 determined by polyacrylamide-gel chromatography. Carbohyydate analysis demonstrated only the presence of glucosamine and mannose. Amino acid analysis revealed that the peptide moiety consisted of eight different amino acids, including two residues of asparagine and one residue of serine, but no threonine. These structural data suggest that the acceptor is a fraction of an asparagine-glucosamine type of glycoprotein.

PLATELET ADHESION AND THROMBIN DEPENDENT AGGREGATION OF PATIENTS WITH AN UREMIC BLEEDING TENDENCY

1987 ◽  
Author(s):  
Jaap J Zwaginga ◽  
Philip G de Groot ◽  
Jan J Sixma
Keyword(s):  
Molecular Weight ◽  
Whole Blood ◽  
Low Molecular Weight Heparin ◽  
Platelet Adhesion ◽  
Umbilical Artery ◽  
Bleeding Time ◽  
Low Molecular Weight ◽  
Bleeding Tendency ◽  
Perfusion Chamber ◽  
Normal Plasma

Five patients with chronic renal insufficiency (CRI) presented a Simplate bleeding time of > 30’, two patients had normal bleeding times (< 9’)- Blood was collected before standard hemodialysis into 19 mM citrate (plasma concentration). It was circulated fojr 5’ through an annular perfusion chamber at a shear of 1300 s™1 over inverted umbilical artery segments. CRI blood’s hematocrit was raised to .3 by adding their own RBC’s. Control whole blood perfusates with Ht .3 were made by addition of their own plasma. After perfusion platelet adhesion on the artery was evaluated by microscope, corrected for platelet count of the perfusate and given as percentage surface covered. Control donors showed a 37.4 ± 5.2% coverage not different from ‘bleeding’ patients 38.0 ± 4.5% ’non bleeding’ CRI patients: 32.3 ± 3.9. We also perfused blood of three ’bleeding’ CRI patients in a new thrombus forming system. In a rectangular perfusion chamber (J Lab Clin Med 1983, 522-532) blood anticoagulated with low molecular weight heparin (Fragmin1, Kabi Vitrum) was circulated over tissue factor containing matrix of 43-phorbol 12-myristate 13-acetate perturbed endothelial cells. Locally formed thrombin stimulated platelet aggregation on this matrix. Aggregation was expressed as percentage of spread platelets covered with aggregates. Perfusions with the following perfusates were performed: whole blood of controls (WBc) and patients (WBp), CRI platelets with normal plasma and RBC’s (A), CRI plasma with normal platelets and RBC’s (B) and normal platelets with normal plasma and RBC’s (C).Platelet adhesion of CRI whole blood is not defective, aggregation, however, is. Uremic platelets in normal plasma may have an adhesion defect (A). The defective aggregation caused by uremic plasma (B) seems to be corrected for uremic platelets in normal plasma (A).

scholarly journals Structure Analysis and Anti-Tumor and Anti-Angiogenic Activities of Sulfated Galactofucan Extracted from Sargassum thunbergii

Marine Drugs ◽  
2019 ◽  
Vol 17 (1) ◽  
pp. 52 ◽  
Author(s):  
Weihua Jin ◽  
Wanli Wu ◽  
Hong Tang ◽  
Bin Wei ◽  
Hong Wang ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Molecular Weight ◽  
High Molecular Weight ◽  
Structure Analysis ◽  
Nmr Spectra ◽  
Low Molecular Weight ◽  
Gel Chromatography ◽  
Sargassum Thunbergii ◽  
Sulfation Pattern ◽  
Fucose Content

Sulfated galactofucan (ST-2) was obtained from Sargassum thunbergii. It was then desulfated to obtain ST-2-DS, and autohydrolyzed and precipitated by ethanol to obtain the supernatant (ST-2-S) and precipitate (ST-2-C). ST-2-C was further fractionated by gel chromatography into two fractions, ST-2-H (high molecular weight) and ST-2-L (low molecular weight). Mass spectrometry (MS) of ST-2-DS was performed to elucidate the backbone of ST-2. It was shown that ST-2-DS contained a backbone of alternating galactopyranose residues (Gal)n (n ≤ 3) and fucopyranose residues (Fuc)n. In addition, ST-2-S was also determined by MS to elucidate the branches of ST-2. It was suggested that sulfated fuco-oligomers might be the branches of ST-2. Compared to the NMR spectra of ST-2-H, the spectra of ST-2-L was more recognizable. It was shown that ST-2-L contain a backbone of (Gal)n and (Fuc)n, sulfated mainly at C4 of Fuc, and interspersed with galactose (the linkages were likely to be 1→2 and 1→6). Therefore, ST-2 might contain a backbone of (Gal)n (n ≤ 3) and (Fuc)n. The sulfation pattern was mainly at C4 of fucopyranose and partially at C4 of galactopyranose, and the branches were mainly sulfated fuco-oligomers. Finally, the anti-tumor and anti-angiogenic activities of ST-2 and its derivates were determined. It was shown that the low molecular-weight sulfated galactofucan, with higher fucose content, had better anti-angiogenic and anti-tumor activities.

The production of polyclonal antibodies against the mycotoxin derivative patulin hemiglutarate

1993 ◽  
Vol 39 (9) ◽  
pp. 861-863 ◽  
Author(s):  
L. J. McElroy ◽  
C. M. Weiss
Keyword(s):  
Molecular Weight ◽  
Bovine Serum Albumin ◽  
Serum Albumin ◽  
Antibody Titer ◽  
Bovine Serum ◽  
Polyclonal Antibodies ◽  
Competitive Elisa ◽  
Low Molecular Weight ◽  
Specific Antibodies ◽  
Indirect Competitive Elisa

The mycotoxin patulin is a toxic, carcinogenic, unsaturated lactone produced by a number of molds. Polyclonal antibodies against patulin hemiglutarate were produced. Specific antibodies against patulin alone, however, were not clearly demonstrated. Because of its low molecular weight, patulin required conjugation to bovine serum albumin (BSA) to increase its immunogenicity. Anti-patulin-hemiglutarate-BSA antibody titer and specificity were determined using indirect and indirect competitive ELISA, respectively. Immunoassays would facilitate detection and quantitation of patulin.Key words: patulin, mycotoxin, antibodies.

Monoclonal antibodies against the capsular K antigen of Escherichia coli (09: K30(A): H12): characterisation and use in analysis of K antigen organisation on the cell surface

1988 ◽  
Vol 34 (10) ◽  
pp. 1159-1165 ◽  
Author(s):  
Mary K. Homonylo ◽  
Sheila J. Wilmot ◽  
Joseph S. Lam ◽  
Leslie A. MacDonald ◽  
Christopher Whitfield
Keyword(s):  
Escherichia Coli ◽  
Molecular Weight ◽  
Monoclonal Antibodies ◽  
Cell Surface ◽  
Molecular Probes ◽  
Low Molecular Weight ◽  
Gel Chromatography ◽  
E Coli ◽  
Capsular Antigen ◽  
K Antigen

Monoclonal antibodies were produced against the capsular antigen of Escherichia coli serotype K(A)30, using a mouse hybridoma system. The antibodies also recognised the chemically identical capsular polysaccharide produced by Klebsiella K20. Chemical modification of the K30 polysaccharide indicated that the glucuronic acid residues found in the E. coli K30 capsular antigen were important in the epitope recognised by these antibodies. Use of the antibodies as molecular probes revealed the presence of two discrete forms of the K30 antigen. One form was comprised of high molecular weight polysaccharide, present as a surface capsular layer. The second form of the antigen was of low molecular weight and was associated with lipopolysaccharide fractions from cell surface polysaccharide extracts. Separation of lipopolysaccharide fractions using gel chromatography in the presence of detergent showed that the low molecular weight K-antigenic fraction comigrated with a lipopolysaccharide lipid A core fraction present in encapsulated E. coli K30 bacteria but absent in acapsular mutants.

scholarly journals Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity

Blood ◽  
1989 ◽  
Vol 74 (2) ◽  
pp. 695-702 ◽  
Author(s):  
SR Reddigari ◽  
AP Kaplan
Keyword(s):  
Molecular Weight ◽  
Monoclonal Antibody ◽  
Binding Site ◽  
Human Plasma ◽  
Light Chain ◽  
Dextran Sulfate ◽  
High Molecular Weight Kininogen ◽  
Contact Activation ◽  
Normal Plasma ◽  
Coagulant Activity

We developed a mouse monoclonal antibody (MoAb 115–21) to human high- molecular-weight kininogen (HK) that recognizes its prekallikrein binding site (residues 565 through 595 of HK). The corresponding synthesized 31-amino acid peptide (peptide IV) was recently shown to retain native HK's prekallikrein binding property. The same peptide bound factor XI also, although less avidly. Our MoAb recognizes purified HK, peptide IV, and the light chain moiety of HK (where the peptide IV resides), as shown by enzyme-linked immunosorbent assay (ELISA) and Western blotting experiments. The apparent dissociation constant for the HK and MoAb 115–21 interaction was 2.2 nmol/L. It does not recognize low-molecular-weight kininogen (LK) with which HK shares its heavy chain moiety or any antigens in human plasma congenitally deficient in kininogens. The binding of MoAb 115–21 to purified light chain of HK was competitively inhibited by peptide IV. In addition, the antibody inhibits HK-dependent clotting activity of normal human plasma and dextran sulfate-mediated activation of prekallikrein in plasma and retards cleavage of HK in normal plasma after contact activation with dextran sulfate. Also, purified Fab fragments of MoAb 115–21 inhibited the HK-dependent coagulant activity and dextran sulfate-mediated prekallikrein activation in normal plasma. Since the kd for HK-MoAb 115– 21 interaction is ten times lower than that of HK-prekallikrein, our data suggest that binding of MoAb 115–21 to HK's peptide IV site increases the free prekallikrein concentration in plasma and thus results in the decreased efficiency of factor XIIa-mediated activation of prekallikrein. Decreased levels of kallikrein thus formed may be responsible for the inhibition of HK-dependent clotting activity and the decrease in rate and extent of HK cleavage in normal plasma on contact activation with dextran sulfate. MoAb 115–21 may thus prove very useful, especially with its high affinity for HK, in further delineation of the role of HK and prekallikrein in contact activation and kinin-related human pathology.

scholarly journals Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides

Blood ◽  
1992 ◽  
Vol 79 (2) ◽  
pp. 430-438
Author(s):  
TC Wun
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Dermatan Sulfate ◽  
Factor Viia ◽  
Threshold Concentration ◽  
Sulfated Polysaccharides ◽  
Low Molecular Weight ◽  
Dependent Manner ◽  
Normal Plasma ◽  
Coagulation Inhibitor

Lipoprotein-associated coagulation inhibitor (LACI) is a plasma-derived protein that inhibits tissue factor (TF)/factor VIIa-induced coagulation in a factor Xa-dependent manner. The roles of endogenous plasma LACI and exogenously added LACI and heparin, in the regulation of coagulation, initiated via the intrinsic and extrinsic pathways, were studied using the activated partial thromboplastin time (APTT) and the modified prothrombin time (PT) assays, respectively. Both LACI- depleted plasma and normal plasma have identical APTTs and similar prolongations of the APTT in response to heparin; both are fully anticoagulated (arbitrarily defined as clotting times of greater than 1 hour) at similar concentrations of heparin. These results indicate that heparin is an effective anticoagulant when coagulation is initiated by the intrinsic pathway and that endogenous LACI is not significantly involved in the regulation of this pathway. The PT of normal plasma is only marginally longer than that of LACI-depleted plasma in the absence of heparin, suggesting that endogenous plasma LACI has a very limited capacity to inhibit TF-induced clotting. However, in the presence of heparin, the PTs of LACI-depleted plasma and normal plasma are different. Prolongation of the PT occurred only moderately and linearly with increasing concentrations of heparin in LACI-depleted plasma. In contrast, normal plasma showed a greater extent of PT prolongation in response to heparin and the plasma became fully anticoagulated at a certain threshold concentration of heparin. These results suggest that LACI serves as a cofactor for heparin and thus greatly enhances the inhibition of TF-induced coagulation. LACI-depleted plasma was supplemented with purified recombinant LACI and/or heparin and the effects on TF-induced clotting were studied. A combination of LACI and heparin greatly enhanced anticoagulation compared with LACI or heparin alone. Many sulfated polysaccharides were also found to enhance the LACI-dependent inhibition of TF-induced clotting. By weight, the relative potencies of these compounds are: low molecular weight heparin (mean Mr, 5,100) greater than unfractionated heparin greater than low molecular weight heparin (mean Mr, 3,700) greater than pentosan polysulfate greater than dermatan sulfate greater than dextran sulfate greater than heparan sulfate. Based on the above results, it is concluded that LACI is a cofactor for heparin in the inhibition of TF- induced clotting and that LACI and sulfated polysaccharides act synergistically in whole plasma.

Sign in / Sign up

Export Citation Format

Share Document